Overuse of radiation therapy when urologists profit from self-referral

IMRT use is 2.5 times greater when self-referral's financial incentives are involved A comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity-modulated radiation therapy (IMRT) for prostate cancer among urologists with an ownership interest in the treatment was due … Continue reading Overuse of radiation therapy when urologists profit from self-referral